rubidium has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dibas, A; Hulet, C; Prasanna, G; Yorio, T | 1 |
| Saunders, R; Scheiner-Bobis, G | 1 |
2 other study(ies) available for rubidium and endothelin-1
| Article | Year |
|---|---|
Inhibition of Na(+)/K(+)-atpase by endothelin-1 in human nonpigmented ciliary epithelial cells.
Topics: Antihypertensive Agents; Biological Transport; Bumetanide; Carrier Proteins; Cells, Cultured; Ciliary Body; Diuretics; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Oligopeptides; Ouabain; Peptides; Pigment Epithelium of Eye; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Receptor, Endothelin A; Receptor, Endothelin B; Rubidium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Time Factors | 2001 |
Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump.
Topics: Animals; Calcium; Cells, Cultured; Endothelial Cells; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Humans; Mitogen-Activated Protein Kinases; Ouabain; Rubidium; Sodium-Potassium-Exchanging ATPase | 2004 |